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1. Introduction 
Healthcare-associated infections (HAIs) are one of the most common complications in 
hospitalized patients, leading to increased hospitalization, morbidity and mortality and 
associated with additional costs (Geffers and Gastmeier, 2011).  
Urinary tract infection (UTI) is common in hospitalized patients. It has been reported that in 
U.S. hospitals, among adults and children outside of the intensive care units (ICUs), the 
urinary tract is the most common site of HAI, accounting for 36% of infections, followed by 
surgical site infections (20%), bloodstream infections and pneumonia (11%, each) and other 
infection types (all 22%) (Klevens et al., 2007).  
Almost all healthcare-associated UTIs are caused by instrumental urinary tract 
procedures. In fact, the presence of a foreign body in the urinary tract predisposes the 
patient to UTI and alters the body’s ability to eradicate bacteria (Gray et al., 2010). It has 
been estimated that more than 80% of UTIs are associated with an indwelling catheter 
(Anderson et al., 2007) and notably, catheter-associated UTI (CAUTI) has been related 
with such complications that prolonged hospital stay, and increased cost, morbidity and 
mortality (Gould et al., 2009). 
Urologic patients should be considered at high risk for a healthcare-associated UTI, 
because they are usually exposed both to urethral catheterization and instrumentation of 
the urinary tract. In a surveillance study conducted in an urologic clinic of an Italian 
university hospital  the incidence of symptomatic UTIs was 1.4 per 1000 patient-days 
(Agodi et al., 2007).  
1.1 Epidemiology of UTI in intensive care units 
Since of intrinsic (such as, severity of illness or impaired immunity) and extrinsic (such as, 
devise exposure: mechanical ventilation, urinary and central line catheterization) risk 
factors, patients admitted in ICUs are at high risk of HAIs (Lambert et al., 2011). 
Particularly, in Europe, the Annual Epidemiological Report on Communicable Diseases in Europe 
of the European Centre for Disease Prevention and Control (ECDC, 2009), show that 3% of 
patients staying more than two days in ICUs, acquire bloodstream infections, and 6.2% of 
patients acquire pneumonia. 
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UTI is one of the most common infection in ICU. The mean incidence density of UTI in 
patients admitted in European ICUs is 5.4 UTI episodes per 1000 patient-days. The majority 
of UTI (96.2%) are associated with the use of a urinary catheter (HELICS, 2005), that is the 
most important risk factor for development of UTI (Meddings et al., 2010). It has been 
reported that about 15% - 25% of patients may be exposed to short-term indwelling urinary 
catheters (Warren JW, 2001) and in several cases, catheters are placed for inappropriate 
indications.   Urinary catheters are used frequently in ICUs for correct monitoring of urinary 
output, but, once inserted, catheters tend to remain in place until appropriate indications for 
their use end and thus CAUTI incidence increases as the duration of catheter use increases. 
Use of urinary catheters in the ICU causes breaches in the mucosa or may provide a surface 
for colonization, thus, increasing the incidence of CAUTI. The risk for infection is at least 5% 
per day of catheterization (Tissot et al., 2001; Elpern et al., 2009).   
Other factors have been reported as potential risk factors for CAUTI including constitutional 
factors such as female gender, pregnancy and older age and potential modifiable factors 
such as poor nutrition, fecal incontinence, use of systemic antibiotics, severity of illness, 
impaired immune system function, and elevated creatinine level (Gray, 2010).  
A recent multicenter study was conducted in a cohort of patients from 10 countries 
(Argentina, Brazil, Colombia, Greece, India, Lebanon, Mexico, Morocco, Peru, and Turkey) 
to estimate the excess length of stay (LOS) and mortality in ICU due to CAUTI. Results 
show that CAUTI lead to a small increase LOS in ICU, particularly, prolonging length of 
ICU stay by an average of 1.59 days, but CAUTI increase the risk of death by 15% (Rosenthal 
et al., 2011). 
Thus, it is necessary to implement every possible preventive measure that have proven 
useful in the prevention of CAUTI. 
Furthermore, UTIs are often underdiagnosed due the lack of physician requesting 
systematic laboratory tests and urine cultures (Agodi et al., 2007). Diagnosis, particularly in 
the ICU setting, is very difficult, as asymptomatic bacteriuria may be hard to be 
differentiated from symptomatic UTI (Shuman and Chenoweth, 2010).  
The National Healthcare Safety Network (NHSN) is a system for the surveillance of HAI 
that aggregates data of surveillance, reported by hospitals participating in the network, into 
a single national database (Edwards et al., 2007). In the framework of the “Patient Safety 
component” of the NHSN, data are collected using standardized methods and definitions 
and are grouped into specific module protocols. Particularly, in the device-associated 
module infection control professionals collect data on CAUTIs that occur in patients staying 
in a patient care location such as an ICU, specialty care area, or ward. Indicators are 
calculated in terms of urinary catheter associated infection rate and urinary catheter 
utilization ratio (Table 1).  
 
Indicator  
Urinary catheter associated 
infection rate  
Number of urinary catheter-associated UTI  x 1000 
Number of urinary catheter-days  
Urinary catheter utilization 
ratio 
Number of urinary catheter-days 
Number of patient-days 
Table 1. Calculation of urinary catheter-associated infection rate and urinary catheter 
utilization ratio. 
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The NHSN reports that in 2006 pooled mean urinary catheter utilization ratios in ICU and 
non-ICU wards ranged from 0.23 in inpatient medical/surgical ward to 0.91 in trauma ICU. 
The pooled mean of CAUTI rates ranged from 3.1 infections per 1000 catheter-days in 
medical/surgical ICU to 7.5 infections per 1000 catheter-days in burn ICUs.  
In Europe, the German National Reference Centre for surveillance of nosocomial infections 
was started in 1997 creating a nationwide surveillance system: the Krankenhaus Infektions 
Surveillance System (KISS) (Gastmeier et al., 2008). The surveillance methods of the 
National Nosocomial Infections Surveillance (NNIS) System (Garner et al. 1988; Emori et al., 
1991) were used and for diagnosing HAIs the definitions of the CDC were adopted. 
Surveillance data obtained from January 2005 to December 2009 in German ICUs, report an 
urinary catheter utilization ratio of 0.81 and a CAUTI rate of 1.97 per 1000 device-days 
(Geffers and Gastmeier, 2011).  
1.2 Case definitions of UTI  
Major challenges in appraising the quality of evidence in the CAUTI literature are 
represented by the limitations due to heterogeneity of definitions of UTI used in various 
published studies. Researchers have often used numerous different definitions for UTI, 
ranging from simple bacteriuria to symptomatic infection defined by combinations of 
bacteriuria and various signs and symptoms. Furthermore, the heterogeneity of definitions 
may reduce the quality of evidence for a given intervention and often precludes meta-
analyses (Gould et al., 2009). 
Case definition of UTI proposed by the Hospitals in Europe Link for Infection Control 
through Surveillance (HELICS) system is reported in Table 2 (HELICS-ICU, 2004). 
Particularly, in the HELICS protocol three different types of UTIs are identified and 
defined: microbiologically confirmed symptomatic UTI (UTI-A), not microbiologically 
confirmed symptomatic UTI (UTI-B) and asymptomatic bacteriuria (UTI-C) (HELICS-ICU, 
2004). Of note is that UTIs may be added or not, optionally, in the HELICS protocol 
surveillance.  
The case definitions of UTI by the HELICS are similar to the case definition by the Centers 
for Disease Control and Prevention/National Healthcare Safety Network (CDC/NHSN) 
(NHSN Manual; Horan et al., 2008), where CAUTIs are classified into two groups with 
specific sets of criteria for each: symptomatic urinary tract infections (SUTI) and 
asymptomatic bacteriuria (ASB). The only difference is that, in the HELICS, asymptomatic 
bacteriuria is defined as the subcategory UTI-C, and not as a separate category. Otherwise, 
the subcategories UTI-A and UTI-B are the same as respectively criterion 1 and 2 of the 
CDC/NHSN definition of symptomatic urinary tract infection. NHSN in January 2009 has 
revised the UTI definition criteria. Among the changes are removal of the ASB criterion and 
refinement of the criteria for defining symptomatic SUTI. The time period for follow-up 
surveillance after catheter removal also has been shortened from 7 days to 48 hours to align 
with other device-associated infections (NHSN Manual).  
1.3 Pathogenesis of UTIs 
Microorganisms causing CAUTI can be acquired by an endogenous source (such as, via 
meatal, rectal, or vaginal colonization) or an exogenous one (such as, via contaminated 
hands of healthcare personnel or devices).     
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UTI-A: 
microbiologically 
confirmed 
symptomatic UTI 
Patient has at least one of the following signs of symptoms 
with no other recognized cause:  
- Fever (>38°C) 
- Urgency 
- Frequency 
- Dysuria 
- Suprapubic tenderness  
and 
Patient has a positive urine culture (≥ 105 microorganisms per 
ml of urine) with no more than two species of microorganisms 
UTI-B:  
not microbiologically 
confirmed 
symptomatic UTI 
Patient has at least two of the following with no other 
recognized cause:  
- Fever (>38°C) 
- Urgency 
- Frequency 
- Dysuria 
- Suprapubic tenderness  
and, at least one of the following: 
- Positive dipstick for leukocyte esterase and/or nitrate 
- Pyuria urine specimen with ≥10 WBC/ml or ≥ 3 
WBC/high-power field of unspun urine 
- Organisms seen on Gram stain of unspun urine 
- At least two urine cultures with repeated isolation of the 
same uropathogen (gram-negative bacteria or S. 
saprophyticus) with ≥ 102 colonies/ml urine in nonvoided 
specimens ≤105 colonies/ml of a single uropathogen 
(gram-negative bacteria or S. saprophyticus) in a patient 
being treated with effective antimicrobial agent for a 
urinary infection 
- Physician diagnosis of a urinary tract infection 
- Physician institutes appropriate therapy for a urinary  
- infection 
UTI-C:  
asymptomatic 
bacteriuria 
Patient has no fever (>38°C), urgency, frequency, dysuria, or 
suprapubic tenderness 
and either of the following criteria: 
1. Patient has had an indwelling urinary catheter within 7 
days before urine is cultured  
and 
Patient has a urine culture, that is,  ≥105 microorganisms per 
ml of urine with no more than two species of microorganisms.  
2. Patient has not had an indwelling urinary catheter within 
7 days before the first positive culture 
and 
Patient has had at least two positive urine cultures ≥105 
microorganisms per mm3 of urine with repeated isolation of 
the same microorganism and no more than two species of 
microorganisms 
Table 2. Case definition of Urinary Tract Infection (HELICS-ICU, 2004). 
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The NHSN reported that between 2006-2007, the most frequent pathogens associated with 
CAUTI were Escherichia coli (21.4%) and Candida spp. (21.0%), followed by Enterococcus spp. 
(14.9%), Pseudomonas aeruginosa (10.0%), Klebsiella pneumoniae (7.7%), and Enterobacter spp. 
(4.1%). A smaller proportion of CAUTI was caused by other gram-negative bacteria or by 
Staphylococcus spp. (Hidron et al., 2008).  
Finally, it is important to underline that bacteriuria associated to CAUTI commonly leads to 
antimicrobial use, that would have been avoidable, as well as to urinary drainage systems 
that are often reservoirs for multidrug-resistant bacteria and a potential source of 
transmission to other patients (Gould et al., 2009). 
As reported in the Annual Epidemiological Report on Communicable Diseases in Europe (ECDC, 
2010), the antimicrobial resistance of microorganisms is to be considered the most important 
disease threat. In 2008 a Europe-wide increase of resistance to all antibiotic classes under 
surveillance was observed for the most common Gram-negative bacteria – E. coli - 
responsible for bacteraemia and UTIs.  
1.4 Prevention of CAUTI 
CAUTIs are generally considered an avoidable complication. It has been estimated that 
between 17% and 69% of all observed CAUTIs may be prevented by implementation of an 
evidence based prevention program that is particularly important in the ICU setting with a 
high prevalence of urinary catheterization and a high percentage of patients with 
comorbidities (Gould et al., 2009).  
The CDC/Healthcare Infection Control Practices Advisory Committee (HICPAC) published 
a specific document - Guideline for Prevention of Catheter-associated Urinary Tract Infections – 
that addresses the prevention of CAUTI for patients with short- or long-term urinary 
catheterization admitted in any type of healthcare facility and evaluates the evidence for 
several options of methods of urinary drainage, including intermittent catheterization, 
external catheters, and suprapubic catheters (Gould et al., 2009). The guideline is based on a 
specific systematic review of the best available evidence on CAUTI prevention; it uses the 
Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
approach (Atkins et al., 2004; Guyatt et al., 2008a; Guyatt et al. 2008b) in order  to provide 
clear links between the available evidence and the resulting recommendations. 
Particularly, in this document, recommendations include: i) appropriate urinary catheter 
use; ii) proper techniques for urinary catheter insertion; iii) proper techniques for urinary 
catheter maintenance; iv) quality improvement programs; v) administrative infrastructure; 
and vi) surveillance.  
As suggested by the Authors of this guideline further research in order to prevent CAUTIs 
should focuse on catheter materials (antimicrobial and antiseptic-impregnated catheters and 
standard catheters), appropriate urinary catheter use (in incontinent patients and 
appropriate indications for continued use in postoperative patients), use of antiseptics (for 
periurethral cleaning prior to catheter insertion and  to prevent CAUTI), alternatives to 
indwelling urethral catheters and bag drainage (suprapubic catheters, urethral catheters, use 
of catheter valves and other alternative methods of urinary drainage), optimal methods for 
preventing encrustation in long-term catheterized patients, other prevention measures and 
prevention of transmission of pathogens colonizing urinary drainage systems.  
A specific recommendation for the appropriate urinary catheter use (category IB) is: 
“Minimize urinary catheter use and duration of use in all patients, particularly those at 
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higher risk for CAUTI or  mortality from catheterization such as women, the elderly, and 
patients with impaired immunity” (Gould et al., 2009). 
In this contest, a recent study (Elpern et al., 2009) has been conducted in a medical ICU in 
order to implement and evaluate the efficacy of an intervention, based on the decreasing use 
of urinary catheters, to reduce CAUTI. Results of this study report that the implementation 
of an intervention targeting the appropriate use of indwelling urinary catheters may result 
in a significant reduction in the duration of catheterization as well as in the occurrences of 
CAUTIs. 
A systematic literature review and meta-analysis was performed to evaluate the effect of 
interventions that remind clinicians of the presence of urinary catheters to prompt the 
timely removal of catheters during hospitalization. Results of the meta-analysis report that 
the rate of CAUTI was significantly reduced by 52% with the use of a reminder or stop 
order. Furthermore, the mean duration of catheterization decreased by 37%. Thus, 
interventions to routinely prompt physicians or nurses to remove unnecessary urinary 
catheters appear to reduce the rate of CAUTI and should be strongly considered to enhance 
the safety of hospitalized patients (Medding et al., 2010). 
The Institute for Health Care Improvement (IHI) developed the model of “bundles” to help 
health care workers more consistently deliver the best possible care for patients undergoing 
particular treatments (Institute for Health Care Improvement, 2006). “A bundle is a 
structured way of improving the processes of care and patient outcomes: a small, 
straightforward set of evidence-based practices — generally three to five — that, when 
performed collectively and reliably, have been proven to improve patient outcomes” (Resar 
et al., 2005).  
A recent observational study (Venkatram et al., 2010) was conducted in order to study the 
effect of bundle strategies on the device use adjusted rate of HAI in adult medical ICU, to 
prevent HAIs associated with endovascular catheters, mechanical ventilation, and urinary 
tract catheters. Particularly, the UTI bundle regards the use of antimicrobial catheters, closed 
drainage systems, and daily assessment for removal. During the study period, HAIs 
declined from 47 in 2004 to 3 in 2007. Particularly, CAUTI decreased from 6.23 to 0.63 per 
1000 device-days. However, the decline in infection rates cannot be accounted by the decline 
in device use by itself, in fact, when adjusted to device use, the decrease in HAI rates still 
showed statistical significance. Therefore, it is not easy to attribute this decline to any one 
component of the bundle. Results of this study demonstrate that best practices using a 
multidisciplinary bundle strategy including device use can lead to optimal outcomes with 
respect to HCAI rates. 
2. Surveillance of urinary tract infections in ICUs 
Epidemiologic surveillance of HAI in ICUs is an important tool of internal quality 
management in the hospital setting (Zuschneid et al., 2010), and together with appropriate 
infection control activities, can decrease infection rates significantly (Haley et al., 1985).  
A specific recommendation, of category II, included in the CDC/HICPAC Guideline for 
Prevention of Catheter-associated Urinary Tract Infections is: “Consider surveillance for CAUTI 
when indicated by facility-based risk assessment”. Particularly, it is recommended to 
identify the patient groups or units on which to conduct surveillance based on frequency of 
catheter use and potential risk of CAUTI and to use standardized methodology for 
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performing CAUTI surveillance (Category IB). Furthermore, providing regular feedback of 
CAUTI rates to the staff  should be also considered (Gould et al., 2009). 
In order to explore the epidemiologic scenario and control of UTIs in intensive care patients, 
surveillance of HAI was performed on three Sicilian ICUs participating in the first two 
edition of the SPIN-UTI (Sorveglianza Prospettica delle Infezioni Nosocomiali nelle Unità di 
Terapia Intensiva) project.  
2.1 Methods of surveillance 
The Italian Nosocomial Infections Surveillance in ICUs, SPIN-UTI project, established in 
Italy by the Italian Study Group of Hospital Hygiene (GISIO) of the Italian Society of 
Hygiene, Preventive Medicine and Public Health (SItI) (Agodi et al., 2010), started the first 
edition in 2006 - 2007, the second edition of the project was implemented in 2008 – 2009, and 
the third, in 2010 – 2011 is in progress.  
The methodology of surveillance are describes in great details elsewhere (Agodi et al., 2010) 
and is based on the HELICS-ICU protocol, in order to participate in the European 
benchmark (HELICS-ICU, 2004; Suetens et al., 2007). The enrollment of patients was 
prospective, and data regarding ICU stay, patient’s risk factors including exposure to 
invasive devices (such as intubation, central venous catheter and urinary catheter), were 
collected using a web-based data collection procedure for each patient staying longer than 
two days in the ICU (Figure 1).  
The definitions of HAI used in the SPIN-UTI project are the same proposed by the HELICS-
ICU protocol for pneumonia, bloodstream infections (BSIs), central venous catheter-related 
bloodstream infections (CRIs) and UTIs (HELICS-ICU, 2004; Suetens et al., 2007). UTI data 
collection was mandatory. 
The indicators included cumulative incidence and, to adjust for length of stay, incidence 
density. Furthermore, device-associated infection rates and device utilization ratios were 
also calculated as the number of infections per 1000 device-days and the number of days 
with the device divided for the number of patient-days.  
2.2 Web-based data collection and statistical analysis 
Surveillance data collection was performed from all patients enrolled in the project using four 
electronic data forms – designed using SPSS "Data Entry Enterprise Server" - as instruments 
for data collection. Particularly, the following data forms were used: 1) ‘Characteristics of 
hospital and of ICU’, 2) ‘Patient’, 3) ‘Infection’ and 4) ‘Microorganism’ (Figure 1). The 
electronic forms were characterized by functional instruments. Using these electronic forms 
data are entered via Web and each record is sent to the server, where it is automatically routed 
to the appropriate database. Cleaning and analyses were performed using SPSS for Windows 
(version 14.0): univariate analyses and the above reported indicators were calculated. 
Furthermore, categorical variables were compared using the chi-square-test, and continuous 
variables by Student’s t-test; p < 0.05  was considered statistical significant. 
3. Results of surveillance 
3.1 ICU setting 
The study was conducted at three Sicilian ICUs participating in the first two edition of the 
SPIN-UTI Project. The ICU identified as ICU 1 is a 12-bed interdisciplinary ICU, from a 700-
bed acute care hospital; the ICU identified as ICU 2 is a 7-bed interdisciplinary ICU, from a 
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Fig. 1. Methods of Surveillance and web-based data collection. 
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830-bed tertiary care hospital; the ICU identified as ICU 3 is a 6-bed interdisciplinary ICU, 
from a 200-bed tertiary care hospital. 
3.2 Patient’s characteristics and device usage 
A total of 501 patients with length of stay >2 days, for a total of 9681 patient-days, were 
admitted in the three ICUs during the two edition of the SPIN-UTI project and thus were 
enrolled in the study. A summary of patient characteristics and urinary catheter use is 
shown in Table 3.  
 
Characteristic 
ICU 1 ICU 2 ICU 3 Total 
(2006-
07) 
(2008-
09) 
(2006-
07) 
(2008-
09) 
(2006-
07) 
(2008-
09) 
(2006-
07) 
(2008-
09) 
Number of 
patients 
133 80 103 91 44 50 280 221 
Mean age in 
years (range) 
54.4 
(5-94) 
59,3 
(22-92) 
65.8 
(2-94) 
62,6 
(1-97) 
64.7 
(19-87) 
62,9 
(13-87) 
60.2 
(2-94) 
61.5 
(1-97) 
Male (%) 59.8 53,8 53.5 56 43.2 46 54.9 52.9 
Mean SAPS II 
score (range) 
41.85 
(6-98) 
51,58 
(16-87) 
31.38 
(5-64) 
27,41 
(6-62) 
34.06 
(9-68) 
43,80 
(7-114) 
37.37 
(5-98) 
40.84 
(6-114) 
Mean length of 
stay in days 
(range) 
12.92 
(3-65) 
30,23 
(6-106) 
13.86 
(3-79) 
26,71 
(3-120) 
10.55 
(3-57) 
24,42 
(3-84) 
12.9 
(3-79) 
27.47 
(3-120) 
Total length of 
stay in ICU (in 
days) 
1719 1598 1428 1335 464 736 3611 3669 
Urinary 
catheter (%) 
127 
(95.5) 
60 
(75.0) 
102 
(99.0) 
75 
(82.4) 
41 
(93.2) 
36 
(72.0) 
270 
(96.4) 
171 
(77.4) 
Total length of 
urinary 
catheterization 
(in days) 
1576 1565 1269 1297 412 713 3257 3575 
Mean length of 
urinary 
catheter in days 
(range) 
12.5 
(1-65) 
19.8 
(3-106) 
12.6 
(1-79) 
14.3 
(3-87) 
10.1 
(1-58) 
14.9 
(3-78) 
12.2 
(1-79) 
16.4 
(3-106) 
Urinary 
catheter 
utilization 
ratios 
0.92 0.97 0.89 0.97 0.89 0.97 0.90 0.97 
Table 3. Main characteristics of patients included in the study. 
Particularly, in the first edition of the project a total of 280 patients for a total of 3611 patient-
days and a total of 221 patients for a total of 3669 patient-days in the second edition, were 
admitted. During the two edition of the project, a significant reduction of the proportion of 
patients with urinary catheter was observed (chi-square test, p <0.05). Particularly, in the 
first edition the overall proportion of patients with urinary catheter was 96.4% (range: 93.2% 
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- 99.0%) and in the second edition was 77.4% (range: 72.0 – 82.4%). Furthermore, in the first 
edition the total length of urinary catheterization was 3257 days (mean: 12.2 days; range: 1-
79) and increased significantly (comparison between means, Student’s t test, p <0.05), in the 
second edition where was 3575 days (mean 16.4 days; range: 3-106 days).   
Considering all three ICUs, an increase of urinary catheter utilization ratio, from 0.90 to 0.97, 
was observed in the second edition of the project. 
3.3 Infection’s indicators 
Table 4 reports infection’s indicators. Considering all ICUs, in the first edition of the SPIN-
UTI project, the most frequently reported ICU-acquired infection type was pneumonia 
(38.2%) followed by bloodstream infections (30.9%), urinary tract infections (20.9%) and 
central venous catheter-related bloodstream infections (10.0%). In the second edition, the 
most frequently reported ICU-acquired infection type was bloodstream infections (43.7%) 
followed by urinary tract infections (29.1%), pneumonia (23.2%) and central venous 
catheter-related bloodstream infections (4.0%). Thus, in the last edition of the SPIN-UTI 
project an increase of the proportion of infections due to bloodstream infections and to 
urinary tract infections were registered, both considering all ICUs and each ICU separately. 
Instead, a decrease of the proportion of infections due to pneumonia infections and to 
central venous catheter-related bloodstream infections were registered, both considering all 
ICUs and each ICU separately. 
The risk of ICU-acquired infections for all sites was estimated by computing the cumulative 
incidence: 39.3 per 100 patients in the first edition and 68.3 per 100 patients in the second 
one; and the incidence density: 30.5 per 1000 patient-days in the first edition and 41.2 per 
1000 patient-days in the second one. Particularly, the cumulative incidence and the 
incidence density of UTI were increased in the second edition compared with the first one 
(Table 4). 
Notably, in the two edition of the project, all UTIs were related to the presence of urinary 
catheter.  
Urinary catheter-associated UTI rates (i.e. the number of urinary catheter-associated UTI per 
1000 urinary catheter-days) was 7.1 per 1000 urinary catheter-days in the first edition and 
12.3 per 1000 urinary catheter-days in the second edition.  
3.4 Microorganisms associated to HAI 
Considering all infection sites, relative frequencies of the five most common isolated 
microorganisms in ICU-acquired infections are reported in Table 5. 
Despite difference among ICUs (data not shown), in the first edition of the SPIN-UTI project, 
the most frequently reported microorganism associated with ICU-acquired infections 
overall was P. aeruginosa (18.1%), followed by Acinetobacter baumannii (15.5%), S. epidermidis 
(14.7%), K. pneumoniae (7.8%) and E. coli (6.9%). In the second edition A. baumannii became 
the most frequently reported microorganism (20.3%), followed by K. pneumoniae (15.8%), P. 
aeruginosa (12.4%), S. epidermidis (6.8%) and E. coli (4.5%).  
Considering only UTIs, in the first edition of the SPIN-UTI project, the reported 
microorganism overall were P. aeruginosa (30.8%), followed by A. baumannii and Escherichia 
coli (15.4%, each), K. pneumoniae (11.5%), Candida albicans, Candida tropicalis and Enterobacter 
cloacae (11.5%, each) and Enterococcus spp. (3.8%). In the second edition K. pneumoniae 
became the most frequently reported microorganism (22.2%), followed by E. coli and P. 
aeruginosa (13.3%), Enterococcus faecalis (11.1%), A. baumannii and Candida glabrata (8.9%, 
each) and C. albicans (6.7%) (Table 6). 
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ICU 1 ICU 2 ICU 3 Total 
(2006-
07) 
(2008-
09) 
(2006-
07) 
(2008-
09) 
(2006-
07) 
(2008-
09) 
(2006-
07) 
(2008-
09) 
Total number of 
infections 
54 86 52 52 4 13 110 151 
Total number of UTI 
(%) 
10 
(18.5) 
18 
(20.9) 
13 
(25.0) 
22 
(42.3) 
0 
4 
(30.8) 
23 
(20.9) 
44 
(29.1) 
Total number of 
Pneumonia (%) 
24 
(44.4) 
29 
(33.7) 
16 
(30.8) 
5 
(9.6) 
2 
(50.0) 
1 
(7.7) 
42 
(38.2) 
35 
(23.2) 
Total number of CRI 
(%) 
11 
(20.4) 
6 
(7.0) 
0 0 0 0 
11 
(10.0) 
6 
(4.0) 
Total number of BSI 
(%) 
9 
(16.7) 
33 
(38.4) 
23 
(44.2) 
25 
(48.1) 
2 
(50.0) 
8 
(61.5) 
34 
(30.9) 
66 
(43.7) 
Total length of stay in 
ICU (in days) 
1719 1598 1428 1335 464 736 3611 3669 
Cumulative incidence 
of infection (all sites) 
(/100 patients) 
40.6 107.5 50.5 57.1 9.1 26.0 39.3 68.3 
Incidence density of 
infection (all sites) 
(/1000 patient-days) 
31.4 53.8 36.4 39.0 8.6 17.7 30.5 41.2 
Cumulative incidence 
of UTI 
(/100 patients) 
7.5 22.5 12.6 24.2 0 8.0 8.2 19.9 
Incidence density of 
UTI 
(/1000 patient-days) 
5.8 11.3 9.1 16.5 0 5.4 6.4 12.0 
Cumulative incidence 
of Pneumonia (/100 
patients) 
18.0 36.3 15.5 5.5 4.5 2 15.0 15.8 
Incidence density of 
Pneumonia 
(/1000 patient-days) 
14.0 18.1 11.2 3.7 4.3 1.4 11.6 9.5 
Cumulative incidence 
of CRI 
(/100 patients) 
8.3 7.5 0 0 0 0 3.9 2.7 
Incidence density of 
CRI 
(/1000 patient-days) 
6.4 3.8 0 0 0 0 3.0 1.6 
Cumulative incidence 
of BSI 
(/100 patients) 
6.8 41.2 22.3 27.5 4.5 16.0 12.1 29.9 
Incidence density of 
BSI 
(/1000 patient-days) 
5.2 20.7 16.1 18.7 4.3 10.9 9.4 18.0 
Table 4. Infection’s indicators in the three ICUs. 
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All ICUs 
(all infection types) 
(2006-07) (2008-09) 
1st microorganism (n; %) P. aeruginosa (21; 18.1) A. baumannii (36; 20.3) 
2nd microorganism (n; %) A. baumannii (18; 15.5) K. pneumoniae (28; 15.8) 
3rd microorganism (n; %) S. epidermidis (17; 14.7) P. aeruginosa (22; 12.4) 
4th microorganism (n; %) K. pneumoniae (9; 7.8) S. epidermidis (12; 6.8) 
5th microorganism (n; %) E. coli (8; 6.9) E. coli (8; 4.5) 
Table 5. Relative frequencies of the five most common isolated microorganisms in ICU-
acquired infections. 
 
All ICUs 
(only UTIs: n; %) 
(2006-07) (2008-09) 
P. aeruginosa 
(8; 30.8) 
K. pneumoniae 
(10; 22.2) 
E. coli and A. baumannii 
(4; 15.4, each) 
E. coli and P. aeruginosa 
(6; 13.3, each) 
K. pneumoniae 
(3; 11.5) 
E. faecalis 
(5; 11.1) 
C. albicans, C. tropicalis, E. cloacae 
(2; 7.7, each) 
A. baumannii and C. glabrata 
(4; 8.9, each) 
Enterococcus spp. 
(1; 3.8) 
C. albicans 
(8; 6.7) 
Table 6. Relative frequencies of the isolated microorganisms in UTIs. 
4. Discussion 
In several high-income countries, device-associated HAI surveillance in the ICU plays a 
considerable role in hospital infection control and quality assurance (Edwards et al., 2009).  
A recent study was performed in the framework of the German KISS with the aim of 
investigating whether surveillance of CAUTI in ICUs leads to reduced infection rates. When 
comparing the symptomatic CAUTI rates in the third and first years of the surveillance, a 
significant reduction in CAUTI was shown. However, before-and-after studies are limited 
by confounding variables such as the difficulties of ICU patients in recognizing and 
reporting UTI symptoms, that leads to the availability of microbiological reports as a major 
criterion for diagnosing symptomatic UTI. Thus, in the case of CAUTI diagnosis, 
microbiological reports may have decreased over time and  have influenced reduction of 
CAUTI rates (Gastmeier et al., 2011).  
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In the same study, it has been reported that the overall surveillance effect was highest for 
ventilator-associated pneumonia and central venous catheter bloodstream infection. This 
could be explained by the perception of the clinicians that ventilator-associated pneumonia 
and central venous catheter bloodstream infection are more serious infections demanding 
more effective responses rather than CAUTI. However, CAUTI may also lead to sepsis, and 
changes in CAUTI rate over time, with consistent microbiology diagnostic procedures, may 
lead to the introduction of appropriate infection control measures (Gastmeier et al., 2011). 
The SPIN-UTI project was implemented to create a HAI surveillance network of Italian ICUs 
(Agodi et al., 2010). The validation study of the SPIN-UTI project has showed a high 
sensitivity, specificity, and positive and negative predictive values of surveillance data 
(Masia et al., 2010). 
Comparison of results of the two editions of the SPIN-UTI project revealed that, the risk of 
ICU-acquired infections for all sites, estimated by computing the cumulative incidence and 
the incidence density, increased in the second edition compared to the first one.  
Differences were presented considering infection by site. In the second edition of the project 
a decrease of the proportion of infections due to pneumonia and to CRIs were registered. On 
the contrary, an increase of the proportion of infections due to BSIs and to UTIs were 
observed, either considering all ICUs or each ICU separately. Particularly, after comparing 
results of the two studies, in the second edition a higher proportion of the patients acquired 
a UTI in ICU than in the first edition. The cumulative incidence of UTI increased from 8.2 
per 100 patients to 19.9 per 100 patients. The incidence density also increased from 6.4 per 
1000 patient-days to 12.0 per 1000 patient-days. 
Hospital wide prevalence rates for indwelling catheterization vary from 25% to 35% (Haley 
et al., 1981; Junkin & Selekof, 2007). Prevalence rates in ICU are substantially higher at 67% 
to 76% (Huang et al., 2004; Gray, 2010). In our study, a high proportion of patients were 
with urinary catheter (range: 72.0%- 99.0%), and although a significant reduction of the 
proportion of exposed patients was observed in the second edition of the project an increase 
of the mean length of urinary catheterization from 12.2 days to 16.4 days was observed. 
Furthermore, urinary catheter utilization ratio was significantly higher in the second edition 
compared with the first edition (from 0.90 to 0.97).   
Notably, in the two edition of the project, all UTIs were related to the presence of urinary 
catheter. Urinary catheter-associated UTI rates increased from 7.1 per 1000 urinary catheter 
days in the first edition and 12.3 per 1000 urinary catheter days in the second edition.  
It is advised that device-associated infection rates and device utilization ratios should be 
examined together so that preventive measures may be appropriately targeted. Since 
urinary catheter use is a significant risk factor for UTI, efforts must be redirected to reducing 
their use or limiting the duration with which they are used and to addressing the best 
consensus guidelines and recommendations in their insertion and maintenance (Edwards et 
al., 2007). In fact, it has been reported that targeted strategies for prevention of UTI include 
limiting the use and duration of urinary catheterization, using aseptic technique for catheter 
insertion, and adhering to proper catheter care (Shuman and Chenoweth, 2010).  
The most frequently isolated microorganisms causing CAUTI in the ICU setting are enteric 
Gram-negative bacilli, enterococci, Candida species, and P. aeruginosa (Shuman and 
Chenoweth, 2010). Microorganisms are often multidrug resistant probably following the 
increasing use of broad-spectrum antibiotics in hospitals and this is a considerable problem 
in ICU.  
In our surveillance survey, despite difference among ICUs, in the first edition of the project, 
the most frequently reported microorganism associated to UTI was P. aeruginosa, in the 
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second one, K. pneumoniae (22.2%) was the first species isolated. Notably, in the second 
edition an increase of K. pneumoniae isolation and a decrease of P. aeruginosa isolation were 
observed.    
5. Conclusion 
Our study represents a contribution to improve the quality of care in the ICU setting. A 
major item was identified for planning future intervention: focusing on the appropriate 
urinary catheter use. HAIs can be prevented by constant use of “bundles” of simple and 
effective measures, including the monitoring of device use, recommended by CDC and IHI 
(Institute for Health Care Improvement, 2006; Gould et al., 2009). To improve patient safety, 
an integrated, multimodal and comprehensive “bundles” approach is the means to reducing 
the impact of HAI. 
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